Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

Item

http://www.wikidata.org/entity/Q38401252

Q38401252

about

Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial Drug coated balloon angioplasty in the treatment of peripheral artery disease.Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.[Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].Drug-delivering endovascular treatment versus angioplasty in artery occlusion diseases: a systematic review and meta-analysis.Drug-coated balloon in superficial femoral artery in-stent restenosis.Treatment of Femoropopliteal Artery In-stent Restenosis.

P2860

Q28080110-E918EF0D-FD88-4D95-800B-568FABCD185D Q38373320-6DE999AF-350A-4C6E-B085-1495E93ACD4A Q38827478-C664E970-EC41-4715-A06C-66A7F3D63F11 Q38968545-E556AD10-B581-45CF-BC6A-651B40440DA8 Q40905783-628B85E6-CB3E-4FD6-83DD-EAE74DA0C133 Q51823045-9E873B12-E4D7-4106-8703-F2D3CB277CFB Q55304854-CB91815A-61E1-4D2D-8359-46C46D564D96 Q55422201-61FC9748-6599-4B86-A7FC-13B02E4158D6

P2860

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

Item

http://www.wikidata.org/entity/Q38401252

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Paclitaxel-Eluting Balloon vs ...... sults of the DEBATE-ISR Study.

@en

type

Item

label

Paclitaxel-Eluting Balloon vs ...... sults of the DEBATE-ISR Study.

@en

prefLabel

Paclitaxel-Eluting Balloon vs ...... sults of the DEBATE-ISR Study.

@en

P1476

Paclitaxel-Eluting Balloon vs ...... sults of the DEBATE-ISR Study.

@en

P2093

Filippo Turini

http://www.w3.org/2001/XMLSchema#string

Francesco Liistro

http://www.w3.org/2001/XMLSchema#string

Giorgio Ventoruzzo

http://www.w3.org/2001/XMLSchema#string

Giovanni Falsini

http://www.w3.org/2001/XMLSchema#string

Guido Bellandi

http://www.w3.org/2001/XMLSchema#string

Italo Porto

http://www.w3.org/2001/XMLSchema#string

Kenneth Ducci

http://www.w3.org/2001/XMLSchema#string

Leonardo Bolognese

http://www.w3.org/2001/XMLSchema#string

Lucia Ricci

http://www.w3.org/2001/XMLSchema#string

Paolo Angioli

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience.

Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.

Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study.

Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation.

Impact of critical limb ischemia on long-term cardiac mortality in diabetic patients undergoing percutaneous coronary revascularization.

Drug-coated balloon therapy in coronary and peripheral artery disease.

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

P304

52-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1526602815614555

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Grotti

P577

2015-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26511896

http://www.w3.org/2001/XMLSchema#string

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

about

P2860

P2860

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698